Skip to main content
. 2018 Dec;138(12):2617–2624. doi: 10.1016/j.jid.2018.05.023

Table 5.

Development of a risk prediction model for each dataset using model selection1

Variable Selected Australian Model, Odds Ratio (95% CI)2 Leeds Model, Odds Ratio (95% CI)2
Traditional risk factors
 Family history of melanoma
 None 1.00 1.00
 1 or more relative 1.61 (1.05–2.48) 3.38 (1.33–8.59)
 Hair color
 Dark brown/black 1.00 1.00
 Light brown 1.01 (0.71–1.44) 1.15 (0.79–1.68)
 Fair or blonde 1.82 (1.16–2.86) 2.13 (1.32–3.42)
 Red 2.76 (1.36–5.60) 1.86 (0.96–3.58)
 Nevus density
 None 1.00 1.00
 Few 1.19 (0.57–2.48) 1.84 (1.09–3.11)
 Some 3.13 (1.50–6.52) 3.93 (2.27–6.79)
 Many 5.36 (2.43–11.83) 4.64 (2.36–9.15)
 Nonmelanoma skin cancer
 No 1.00 1.00
 Yes 2.28 (1.19–4.37) 3.86 (0.77–19.40)
 Blistering sunburn as a child
 None 1.00
 1 or more episodes 0.80 (0.58–1.11)
 Sunbed use
 None 1.00
 1–10 sessions 0.96 (0.61–1.51)
 >10 sessions 1.79 (1.01–3.20)
 Freckling as an adult
 None/very few 1.00
 Few/some/many 0.73 (0.52–1.02)
 Eye color
 Brown or black 1.00
 Green or hazel 1.05 (0.68–1.63)
 Blue or grey 1.39 (0.89–2.16)
 Sun exposure hours on weekends and vacations
 Quartile 1 (lower exposure) 1.00
 Quartile 2 0.52 (0.34–0.81)
 Quartile 3 0.61 (0.39–0.96)
 Quartile 4 (higher exposure) 0.44 (0.27–0.72)
Genomic variants
 rs7412746 (ARNT) 0.85 (0.67–1.06) 0.81 (0.65–1.02)
 rs62211989 (ASIP) 1.90 (1.33–2.71) 1.91 (1.28–2.84)
 R151C (MC1R) 2.59 (1.77–3.79) 2.75 (1.83–4.13)
 R160W (MC1R) 1.47 (1.00–2.16) 1.70 (1.15–2.51)
 rs2487999 (OBFC1) 1.40 (0.95–2.06) 1.37 (0.93–2.01)
 rs132985 (PLA2G6) 1.19 (0.95–1.48) 0.85 (0.68–1.06)
 rs1393350 (TYR) 1.32 (1.03–1.70) 1.20 (0.95–1.52)
 rs6949072 (AGR3) 1.28 (0.94–1.74)
 rs7274597 (ASIP) 0.50 (0.31–0.81)
 rs76699054 (CCND1) 1.40 (0.93–2.12)
 rs12527588 (CDKAL1) 1.56 (0.95–2.55)
 rs3731217 (CDKN2A) 0.79 (0.57–1.09)
 D84E (MC1R) 2.18 (1.02–4.67)
 I155T (MC1R) 2.60 (1.09–6.18)
 V60L (MC1R) 1.74 (1.21–2.50)
 V92M (MC1R) 1.70 (1.17–2.49)
 rs45430 (MX2) 0.72 (0.57–0.90)
 rs3219090 (PARP1) 0.73 (0.58–0.93)
 rs2736100 (TERT) 0.74 (0.59–0.94)
 rs34585474 (AGR3) 1.27 (0.89–1.83)
 rs7781130 (AGR3) 1.59 (0.85–2.96)
 rs1801516 (ATM) 0.77 (0.55–1.07)
 rs700635 (CASP8) 1.27 (0.99–1.63)
 rs7776158 (CDKAL1) 1.36 (1.06–1.75)
 rs16953002 (FTO) 1.27 (0.93–1.73)
 R163Q (MC1R) 0.62 (0.36–1.09)
 D294H (MC1R) 4.11 (1.62–10.46)
 rs6517661 (MX2) 0.75 (0.53–1.07)
 rs113908778 (RAD23B) 0.55 (0.24–1.24)
 rs4436178 (RAD23B) 1.87 (0.82–4.26)

Abbreviation: CI, confidence interval.

1

A risk prediction model was developed separately for each dataset using a backward selection process in which traditional and genomic risk factors with P < 0.20 were retained in the multivariable model in addition to forced variables age, sex, city of recruitment, and European ancestry. The same genetic variants and traditional risk factors were assessed for inclusion in both models.

2

Odds ratios derived from the respective dataset, adjusted for all other variables in the model. For genomic variants, the per-allele odds ratio is presented. Values left blank indicate that the factor was not included in the final model for that dataset (Australia/Leeds). The areas under the curve for the Australian model were 0.80 (95% CI = 0.77–0.83) from the development model, 0.77 (95% CI = 0.74–0.80) from internal validation (10-fold cross-validation), and 0.72 (95% CI = 0.69–0.75) from external validation using the Leeds dataset. The areas under the curve for the Leeds model were 0.77 (95% CI = 0.73–0.80) from the development model, 0.72 (95% CI = 0.69–0.75) from internal validation, and 0.77 (95% CI = 0.74–0.80) from external validation using the Australian dataset. Both models were well calibrated in the external datasets (Hosmer-Lemeshow P = 0.57 for both).